Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 5/20 | 0.37 |
| ▸ | DRD2 | P14416 | 4/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.34 |
| ▸ | VNN1 | O95497 | 1/20 | 0.33 |
| ▸ | HSD17B13 | Q7Z5P4 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | METAP2 | P50579 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | SMURF2 | Q9HAU4 | 1/20 | 0.30 |
| ▸ | SMURF1 | Q9HCE7 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5310762 | 0.99 | SLC2A1 (0.36) | SLC2A1DRD2SLC6A3VNN1HSD17B13 | |
| SCHEMBL5308537 | 0.90 | SLC2A1 (0.36) | SLC2A1DRD2SLC6A3VNN1HSD17B13 | |
| Hydrochloric Acid SCHEMBL5308736 | 0.90 | SLC2A1 (0.36) | SLC2A1DRD2SLC6A3VNN1HSD17B13 | |
| SCHEMBL5576958 | 0.87 | DRD2 (0.36) | DRD2SLC6A3TDP1HDAC6METAP2 | |
| SCHEMBL5308109 | 0.86 | PTGS1 (0.37) | SLC2A1DRD2SLC6A3VNN1HSD17B13 | |
| SCHEMBL5576963 | 0.86 | DRD2 (0.35) | DRD2SLC6A3METAP2SLC6A2 | |
| Hydrochloric Acid SCHEMBL5313916 | 0.85 | PTGS1 (0.37) | SLC2A1DRD2SLC6A3VNN1HSD17B13 | |
| SCHEMBL14529640 | 0.84 | HSD17B13 (0.36) | SLC2A1DRD2SLC6A3VNN1HSD17B13 | |
| SCHEMBL14513390 | 0.81 | SLC2A1 (0.46) | SLC2A1 | |
| Hydrochloric Acid SCHEMBL5330503 | 0.80 | SLC2A1 (0.46) | SLC2A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007052831-A1 | PREVENTIVES/REMEDIES FOR URINARY DISTURBANCE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-05-10 | — | — | WO | disclosed |
| US-20070099986-A1 | Preventives/remedies for urinary disturbance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-05-03 | — | — | US | disclosed |
| US-20070099986-A1 | Preventives/remedies for urinary disturbance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-05-03 | — | — | US | disclosed |
| US-20070099986-A1 | Preventives/remedies for urinary disturbance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099986-A1 | Preventives/remedies for urinary disturbance | REN, GLS, ATP6V1B1 | SLC2A1 390/4885DRD2 1113/4885SLC6A3 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.